Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry

Analytical and Bioanalytical Chemistry

Volumn 407, Issue 2, 2015, Pages 405-414

  Arnhard, Kathrin ^a   Gottschall, Anna ^a   Pitterl, Florian ^a   Oberacher, Herbert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Information dependent acquisition control; Information independent acquisition control; Liquid chromatography tandem mass spectrometry; Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra (SWATH); Systematic toxicological analysis; Tandem mass spectral library

Indexed keywords

AUTOMATION; CHROMATOGRAPHY; DATA ACQUISITION; DRUG PRODUCTS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; IONS; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; SPECTROMETRY;

FRAGMENT IONS; INFORMATION-DEPENDENT ACQUISITIONS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; SYSTEMATIC TOXICOLOGICAL ANALYSIS; TANDEM MASS;

LIQUID CHROMATOGRAPHY;

LIDOCAINE; MIDAZOLAM; MORPHINE;

COMPUTER PROGRAM; DEVICES; FORENSIC TOXICOLOGY; HUMAN; LIQUID CHROMATOGRAPHY; PROCEDURES; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING; TANDEM MASS SPECTROMETRY; TOXICOLOGY; URINE;

CHROMATOGRAPHY, LIQUID; FORENSIC TOXICOLOGY; HUMANS; LIDOCAINE; MIDAZOLAM; MORPHINE; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING, COMPUTER-ASSISTED; SOFTWARE; TANDEM MASS SPECTROMETRY; TOXICOLOGY;

EID: 84937937624     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-014-8262-1     Document Type: Article

References (50)

1. Maurer HH (2013) What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening? J Chromatogr A 1292:19-24. doi: 10.1016/j.chroma.2012.08.069
2. Peters FT (2011) Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin Biochem 44:54-65. doi: 10.1016/j.clinbiochem.2010.08.008
3. Kraemer T, Paul LD (2007) Bioanalytical procedures for determination of drugs of abuse in blood. Anal Bioanal Chem 388(7):1415-1435. doi: 10.1007/s00216-007-1271-6
4. Dresen S, Ferreirós N, Gnann H, Zimmermann R, Weinmann W (2010) Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP® LC-MS/MS system and library searching. Anal Bioanal Chem 396:2425-2434. doi: 10.1007/s00216-010-3485-2
5. Remane D, Wetzel D, Peters FT (2014) Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for screening of urine specimens for 100 analytes relevant in drug-facilitated crime (DFC). Anal Bioanal Chem 406:4411-4424. doi: 10.1007/s00216-014-7841-5
6. Oberacher H, Schubert B, Libiseller K, Schweissgut A (2013) Detection and identification of drugs and toxicants in human body fluids by liquid chromatography-tandem mass spectrometry under data-dependent acquisition control and automated database search. Anal Chim Acta 770:121-131. doi: 10.1016/j.aca.2013.01.057
7. Wissenbach DK, Meyer MR, Remane D, Weber AA, Maurer HH (2011) Development of the first metabolite-based LC-MSn urine drug screening procedure-exemplified for antidepressants. Anal Bioanal Chem 400:79-88. doi: 10.1007/s00216-010-4398-9
8. Broecker S, Herre S, Wüst B, Zweigenbaum J, Pragst F (2011) Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition. Anal Bioanal Chem 400:101-117. doi: 10.1007/s00216-010-4450-9
9. Saint-Marcoux F, Lachâtre G, Marquet P (2003) Evaluation of an improved general unknown screening procedure using liquid-chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography - diode array detection. J Am Soc Mass Spectrom 14:14-22. doi: 10.1016/S1044-0305(02)00801-2
10. Decaestecker TN, Vande Casteele SR, Wallemacq PE, Van Peteghem CH, Defore DL, Van Bocxlaer JF (2004) Information-dependent acquisition-mediated LC-MS/MS screening procedure with semiquantitative potential. Anal Chem 76(21):6365-6373. doi: 10.1021/ac0492315
11. Weinmann W, Wiedemann A, Eppinger B, Renz M, Svoboda M (1999) Screening for drugs in serum by electrospray ionization/collision-induced dissociation and library searching. J Am Soc Mass Spectrom 10:1028-1037. doi: 10.1016/S1044-0305(99)00070-7
12. Fitzgerald RL, Rivera JD, Herold DA (1999) Broad spectrum drug identification directly from urine, using liquid chromatography-tandem mass spectrometry. Clin Chem 45:1224-1234
13. Oberacher H, Pavlic M, Libiseller K, Schubert B, Sulyok M, Schuhmacher R, Csaszar E, Kofeler HC (2009) On the inter-instrument and inter-laboratory transferability of a tandem mass spectral reference library: 1. Results of an Austrian multicenter study. J Mass Spectrom 44:485-493. doi: 10.1002/jms.1545
14. Oberacher H, Pavlic M, Libiseller K, Schubert B, Sulyok M, Schuhmacher R, Csaszar E, Kofeler HC (2009) On the inter-instrument and the inter-laboratory transferability of a tandem mass spectral reference library: 2. Optimization and characterization of the search algorithm. J Mass Spectrom 44:494-502. doi: 10.1002/jms.1525
15. Oberacher H, Pitterl F, Siapi E, Steele BR, Letzel T, Grosse S, Poschner B, Tagliaro F, Gottardo R, Chacko SA, Josephs JL (2012) On the inter-instrument and the inter-laboratory transferability of a tandem mass spectral reference library. 3. Focus on ion trap and upfront CID. J Mass Spectrom 47(2):263-270. doi: 10.1002/jms.2961
16. Oberacher H, Weinmann W, Dresen S (2011) Quality evaluation of tandem mass spectral libraries. Anal Bioanal Chem 400:2641-2648. doi: 10.1007/s00216-010-4598-3
17. Oberacher H, Whitley G, Berger B (2013) Evaluation of the sensitivity of the 'Wiley Registry of Tandem Mass Spectral Data, MSforID' with MS/MS data of the 'NIST/NIH/EPA Mass Spectral Library'. J Mass Spectrom 48:487-496. doi: 10.1002/jms.3184
18. Oberacher H, Whitley G, Berger B, Weinmann W (2013) Testing an alternative search algorithm for compound identification with the 'Wiley Registry of Tandem Mass Spectral Data, MSforID'. J Mass Spectrom 48:497-504. doi: 10.1002/jms.3185
19. Wurtinger P, Oberacher H (2012) Evaluation of the performance of a tandem mass spectral library with mass spectral data extracted from literature. Drug Test Anal 4:235-241. doi: 10.1002/dta.341
20. Chapman JD, Goodlett DR, Masselon CD (2013) Multiplexed and data-independent tandem mass spectrometry for global proteome profiling. Mass Spectrom Rev, in press. doi: 10.1002/mas.21400
21. Wang N, Li L (2008) Exploring the precursor ion exclusion feature of liquid chromatography-electrospray ionization quadrupole time-of-flight mass spectrometry for improving protein identification in shotgun proteome analysis. Anal Chem 80:4696-4710. doi: 10.1021/ac800260w
22. Purvine S, Eppel JT, Yi EC, Goodlett DR (2003) Shotgun collision-induced dissociation of peptides using a time of flight mass analyzer. Proteomics 3:847-850. doi: 10.1002/pmic.200300362
23. Venable JD, Dong MQ, Wohlschlegel J, Dillin A, Yates JR (2004) Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat Methods 1:39-45. doi: 10.1038/nmeth705
24. Wrona M, Mauriala T, Bateman KP, Mortishire-Smith RJ, O'Connor D (2005) 'All-in-One' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching. Rapid Commun Mass Spectrom 19:2597-2602. doi: 10.1002/rcm.2101
25. Panchaud A, Scherl A, Shaffer SA, von Haller PD, Kulasekara HD, Miller SI, Goodlett DR (2009) Precursor acquisition independent from ion count: how to dive deeper into the proteomics ocean. Anal Chem 81:6481-6488. doi: 10.1021/ac900888s
26. Geiger T, Cox J, Mann M (2010) Proteomics on an Orbitrap benchtop mass spectrometer using all-ion fragmentation. Mol Cell Proteomics 9:2252-2261. doi: 10.1074/mcp.M110.001537
27. Gillet LC, Navarro P, Tate S, Rost H, Selevsek N, Reiter L, Bonner R, Aebersold R (2012) Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics 11:O111.016717. doi: 10.1074/mcp.O111.016717
28. Bateman KP, Castro-Perez J, Wrona M, Shockcor JP, Yu K, Oballa R, Nicoll-Griffith DA (2007) MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun Mass Spectrom 21:1485-1496. doi: 10.1002/rcm.2996
29. Monaci L, De Angelis E, Visconti A (2011) Determination of deoxynivalenol, T-2 and HT-2 toxins in a bread model food by liquid chromatography-high resolution-Orbitrap-mass spectrometry equipped with a high-energy collision dissociation cell. J Chromatogr A 1218:8646-8654. doi: 10.1016/j.chroma.2011.10.008
30. Bird SS, Marur VR, Stavrovskaya IG, Kristal BS (2013) Qualitative characterization of the rat liver mitochondrial lipidome using LC-MS profiling and high energy collisional dissociation (HCD) all ion fragmentation. Metabolomics 9:67-83. doi: 10.1007/s11306-012-0400-1
31. Barbara JE, Castro-Perez JM (2011) High-resolution chromatography/time-of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening. Rapid Commun Mass Spectrom 25:3029-3040. doi: 10.1002/rcm.5197
32. Dalsgaard PW, Rode AJ, Pedersen AJ, Rasmussen BS, Windberg CN, Linnet K (2013) Screening of 30 acidic and neutral pharmaceuticals in whole blood by fully automated SPE and UPLC-TOF-MSE. Drug Test Anal 5:254-258. doi: 10.1002/dta.1442
33. Pedersen AJ, Dalsgaard PW, Rode AJ, Rasmussen BS, Muller IB, Johansen SS, Linnet K (2013) Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition. J Sep Sci 36:2081-2089. doi: 10.1002/jssc.201200921
34. Chindarkar NS, Wakefield MR, Stone JA, Fitzgerald RL (2014) Liquid chromatography high-resolution TOF analysis: investigation of MSE for broad-spectrum drug screening. Clin Chem 60:1115-1125. doi: 10.1373/clinchem.2014.222976
35. Rosano TG, Wood M, Ihenetu K, Swift TA (2013) Drug screening in medical examiner casework by high-resolution mass spectrometry (UPLC-MSE-TOF). J Anal Toxicol 37:580-593. doi: 10.1093/jat/bkt071
36. Hopfgartner G, Tonoli D, Varesio E (2012) High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices. Anal Bioanal Chem 402:2587-2596. doi: 10.1007/s00216-011-5641-8
37. Li GZ, Vissers JP, Silva JC, Golick D, Gorenstein MV, Geromanos SJ (2009) Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures. Proteomics 9:1696-1719. doi: 10.1002/pmic.200800564
38. Carvalho PC, Han X, Xu T, Cociorva D, Carvalho Mda G, Barbosa VC, Yates JR (2010) XDIA: improving on the label-free data-independent analysis. Bioinformatics 26:847-848. doi: 10.1093/bioinformatics/btq031
39. Weisbrod CR, Eng JK, Hoopmann MR, Baker T, Bruce JE (2012) Accurate peptide fragment mass analysis: multiplexed peptide identification and quantification. J Proteome Res 11:1621-1632. doi: 10.1021/pr2008175
40. Collins BC, Gillet LC, Rosenberger G, Rost HL, Vichalkovski A, Gstaiger M, Aebersold R (2013) Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system. Nat Methods 10:1246-1253. doi: 10.1038/nmeth.2703
41. Liu Y, Chen J, Sethi A, Li QK, Chen L, Collins B, Gillet LC, Wollscheid B, Zhang H, Aebersold R (2014) Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol Cell Proteomics 13:1753-1768. doi: 10.1074/mcp.M114.038273
42. Liu Y, Huttenhain R, Surinova S, Gillet LC, Mouritsen J, Brunner R, Navarro P, Aebersold R (2013) Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS. Proteomics 13:1247-1256. doi: 10.1002/pmic.201200417
43. Rost HL, Rosenberger G, Navarro P, Gillet L, Miladinovic SM, Schubert OT, Wolski W, Collins BC, Malmstrom J, Malmstrom L, Aebersold R (2014) OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data. Nat Biotechnol 32:219-223. doi: 10.1038/nbt.2841
44. Zhu X, Chen Y, Subramanian R (2014) Comparison of information-dependent acquisition, SWATH, and MSAll techniques in metabolite identification study employing ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. Anal Chem 86:1202-1209. doi: 10.1021/ac403385y
45. Siegel D, Meinema AC, Permentier H, Hopfgartner G, Bischoff R (2014) Integrated quantification and identification of aldehydes and ketones in biological samples. Anal Chem 86:5089-5100. doi: 10.1021/ac500810r
46. Oberacher H (2011) Wiley Registry of Tandem Mass Spectral Data, MSforID. Hoboken, Wiley, ISBN: 978-1-118-03744-7
47. Pavlic M, Libiseller K, Oberacher H (2006) Combined use of ESI-QqTOF-MS and ESI-QqTOF-MS/MS with mass-spectral library search for qualitative analysis of drugs. Anal Bioanal Chem 386:69-82. doi: 10.1007/s00216-006-0634-8
48. Pavlic M, Schubert B, Libiseller K, Oberacher H (2010) Comprehensive identification of active compounds in tablets by flow-injection data-dependent tandem mass spectrometry combined with library search. Forensic Sci Int 197:40-47. doi: 10.1016/j.forsciint.2009.12.019
49. Schubert B, Oberacher H (2011) Impact of solvent conditions on separation and detection of basic drugs by micro liquid chromatography-mass spectrometry under overloading conditions. J Chromatogr A 1218:3413-3422. doi: 10.1016/j.chroma.2011.03.051
50. Houel S, Abernathy R, Renganathan K, Meyer-Arendt K, Ahn NG, Old WM (2010) Quantifying the impact of chimera MS/MS spectra on peptide identification in large-scale proteomics studies. J Proteome Res 9:4152-4160. doi: 10.1021/pr1003856